Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes

Journal: Science

Published: 2018-03-02

DOI: 10.1126/science.aar3246

Affiliations: 17

Authors: 18

Go to article
Institutions FC
Stanford Department of Molecular and Cellular Physiology (MCP), United States of America (USA) 0.13
Stanford Department of Structural Biology, United States of America (USA) 0.13
UCLA Jonsson Comprehensive Cancer Center (JCCC), United States of America (USA) 0.08
UCSF Diabetes Center, United States of America (USA) 0.07
UCSF Department of Medicine (DOM), United States of America (USA) 0.07
Stanford Division of Blood and Marrow Transplantation, United States of America (USA) 0.07
Institute for Stem Cell Biology and Regenerative Medicine (inStem), India 0.07
Ludwig Center at Stanford, United States of America (USA) 0.07
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.06
Department of Biochemistry, UW, United States of America (USA) 0.06
Institute for Protein Design, UW, United States of America (USA) 0.06
Stanford Cancer Institute (SCI), United States of America (USA) 0.04
Stanford School of Medicine, United States of America (USA) 0.03
Stanford Department of Pediatrics, United States of America (USA) 0.03
Stanford Department of Genetics, United States of America (USA) 0.03
Stanford Medicine, United States of America (USA) 0.01

Return